Ads
related to: neuroscience news daily
Search results
Minerva Neurosciences (NASDAQ:NERV) Receives New Coverage from Analysts at StockNews.com
ETF DAILY NEWS· 3 days agoStockNews.com initiated coverage on shares of Minerva Neurosciences (NASDAQ:NERV – Free Report) in a report issued on Sunday morning. The brokerage issued a sell rating on ...
Medtronic elevates Linnea Burman to president of neurovascular unit
MedTech Dive via Yahoo Finance· 22 hours agoIn the role, she led commercial growth strategies and drove a culture of collaboration, the company...
The Post honored by the National Headliner Awards and Association of Health Care Journalists
Washington Post· 14 hours ago… The Post’s analysis of decades of death data found that chronic diseases cost Americans twice as...
Early memory problems in cognitively healthy people linked to Alzheimer's risk
MedicalNewsToday via AOL· 12 hours agoNew research published in Neurology found that cognitively healthy people who self-reported memory...
Another View | The Columbian: FAA reauthorization win for travelers, Congress
The Daily News· 2 days agoDespite well-documented troubles at Boeing, a series of harrowing incidents and growing passenger...
What Our Brains Know About Stocks—But Won’t Tell Us
The Wall Street Journal· 6 days agoThe investors weren’t told the names of the stocks and said they didn’t recognize them. The set of information the investors...These results are...
Ultra-processed foods linked to higher cognitive decline, stroke risk
MedicalNewsToday via AOL· 6 days agoA new study published this week from researchers at Massachusetts General Hospital in Boston finds...
Bristol-Myers Squibb (NYSE:BMY) Shares Down 1.1%
ETF DAILY NEWS· 5 days agoShares of Bristol-Myers Squibb (NYSE:BMY – Get Free Report) fell 1.1% during trading on Thursday . The company traded as low as $41.58 and last traded at $41.89. 3,501,801 shares changed hands ...
Documents of Mundanity | Doreen St. Félix
New York Review of Books· 2 days agoWhile I was preparing for this interview, there was a problem with The New Yorker’s website; when I searched “Doreen St. Felix,” I got what seemed to be...
Johnson & Johnson (NYSE:JNJ) Stock Rating Reaffirmed by Royal Bank of Canada
ETF DAILY NEWS· 6 days agoJohnson & Johnson (NYSE:JNJ – Get Free Report)‘s stock had its “outperform” rating reiterated by research analysts at Royal Bank of Canada in a report issued on Wednesday, Benzinga reports.